1
/
의
1
Elabscience
SKU(재고 관리 코드):PKSH033395
Recombinant Human IL17RA Protein (Fc Tag)(Active)
Recombinant Human IL17RA Protein (Fc Tag)(Active)
Introducing the Recombinant Human IL17RA Protein (FC Tag)(Active), a cutting-edge product designed to revolutionize the field of immunology. This highly advanced protein is meticulously engineered using recombinant technology, ensuring utmost purity and efficacy.
The Recombinant Human IL17RA Protein (FC Tag)(Active) boasts an impressive array of features that set it apart from conventional alternatives. With its fusion to the Fc tag, this protein exhibits enhanced stability and prolonged half-life, enabling prolonged and sustained activity within the biological system.
This innovative product serves as a potent activator of the IL-17 receptor, a crucial component of the immune response. By binding to the receptor, the Recombinant Human IL17RA Protein (FC Tag)(Active) triggers a cascade of signaling events, ultimately leading to the activation of downstream immune pathways. This activation plays a pivotal role in various physiological processes, including inflammation, autoimmune diseases, and host defense against pathogens.
Furthermore, the Recombinant Human IL17RA Protein (FC Tag)(Active) is meticulously manufactured under stringent quality control measures, ensuring its exceptional purity and bioactivity. Rigorous testing procedures guarantee the absence of contaminants, endotoxins, and other impurities, thereby ensuring optimal safety and reliability.
This product is supplied in a lyophilized form, preserving its stability and facilitating convenient storage and transportation. Upon reconstitution, the Recombinant Human IL17RA Protein (FC Tag)(Active) retains its full biological activity, ready to be utilized in a wide range of applications, including cell-based assays, protein-protein interaction studies, and therapeutic research.
In summary, the Recombinant Human IL17RA Protein (FC Tag)(Active) represents a groundbreaking advancement in the field of immunology. Its exceptional purity, enhanced stability, and potent bioactivity make it an indispensable tool for researchers and scientists alike. Experience the power of this cutting-edge protein and unlock new possibilities in the realm of immunological research.
The Recombinant Human IL17RA Protein (FC Tag)(Active) boasts an impressive array of features that set it apart from conventional alternatives. With its fusion to the Fc tag, this protein exhibits enhanced stability and prolonged half-life, enabling prolonged and sustained activity within the biological system.
This innovative product serves as a potent activator of the IL-17 receptor, a crucial component of the immune response. By binding to the receptor, the Recombinant Human IL17RA Protein (FC Tag)(Active) triggers a cascade of signaling events, ultimately leading to the activation of downstream immune pathways. This activation plays a pivotal role in various physiological processes, including inflammation, autoimmune diseases, and host defense against pathogens.
Furthermore, the Recombinant Human IL17RA Protein (FC Tag)(Active) is meticulously manufactured under stringent quality control measures, ensuring its exceptional purity and bioactivity. Rigorous testing procedures guarantee the absence of contaminants, endotoxins, and other impurities, thereby ensuring optimal safety and reliability.
This product is supplied in a lyophilized form, preserving its stability and facilitating convenient storage and transportation. Upon reconstitution, the Recombinant Human IL17RA Protein (FC Tag)(Active) retains its full biological activity, ready to be utilized in a wide range of applications, including cell-based assays, protein-protein interaction studies, and therapeutic research.
In summary, the Recombinant Human IL17RA Protein (FC Tag)(Active) represents a groundbreaking advancement in the field of immunology. Its exceptional purity, enhanced stability, and potent bioactivity make it an indispensable tool for researchers and scientists alike. Experience the power of this cutting-edge protein and unlock new possibilities in the realm of immunological research.
Share
